Fig. 2: Plasma Biomarkers and Hierarchical clustering of individuals with visuoconstructive deficit or normal outcome after mild COVID-19 and the differentially expressed plasma biomarkers. | Molecular Psychiatry

Fig. 2: Plasma Biomarkers and Hierarchical clustering of individuals with visuoconstructive deficit or normal outcome after mild COVID-19 and the differentially expressed plasma biomarkers.

From: Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings

Fig. 2: Plasma Biomarkers and Hierarchical clustering of individuals with visuoconstructive deficit or normal outcome after mild COVID-19 and the differentially expressed plasma biomarkers.

A Differentially expressed plasma biomarkers associated with visuoconstructive deficit after mild COVID-19. Dashed lines = medians; dotted lines = quartiles. CD = visuoconstructive deficit. N for CD = 26; N for normal = 74. B Hierarchical clustering of individuals with visuoconstructive deficit or normal outcome after mild COVID-19 and the differentially expressed plasma biomarkers. C Hierarchical clustering of individuals with visuoconstructive deficit after mild COVID-19 and their upregulated plasma biomarkers. D Comparison of Z-scores at the Rey–Osterrieth Complex Figure (ROCFT) test compared with Kolmogorov-Smirnov statistical test (interquartile).

Back to article page